Drug Trial Radar · NCT01156142
Doxepin Hydrochloride in Treating Oral Mucositis Pain in Patients With Head and Neck Cancer Undergoing Radiation Therapy With or Without Chemotherapy
Last checked: Nov 19, 2026Latest source record: Aug 9, 2017 (this record)Source: ClinicalTrials.govMethods & limitations
Status
Completed
Enrollment
155
Actual
Start
Dec 2010
Primary completion
May 2012
Study completion Mar 2, 2015
Sponsor
- Lead sponsor
- Alliance for Clinical Trials in OncologyAcademic, hospital or other
- Sponsor type
- Academic, hospital or other
- Collaborators
- National Cancer Institute (NCI)
- First posted
- Jul 2, 2010
Design
- Study type
- Interventional
- Phase
- Phase 3
- Allocation
- Randomized
- Model
- Crossover
- Masking
- Double (participant, investigator)
- Primary purpose
- Supportive care
- Who can join
- All sexes, from 18 years
- Healthy volunteers
- No
Summary
As written by the sponsor on the registry.
RATIONALE: Doxepin hydrochloride may be an effective treatment for oral mucositis pain in patients undergoing radiation therapy with or without chemotherapy. PURPOSE: This randomized phase III trial is studying doxepin hydrochloride to see how well it works compared to placebo in treating oral mucositis pain in patients with head and neck cancer undergoing radiation therapy with or without chemotherapy.
Conditions
- Head and Neck Cancer
- Mucositis
- Oral Complications of Radiation Therapy
- Pain
Interventions
doxepin hydrochlorideDrug
Oral rinse
placeboOther
Oral rinse
Primary outcomes
What the sponsor says the trial is designed to measure.
- Total Pain Reduction (Mouth and Throat)Time frame: Baseline and Day 1
Locations
120 sites in 1 country. Site status is shown where the registry gives one.
Mayo Clinic Scottsdale
Scottsdale, Arizona
Saint Francis/Mount Sinai Regional Cancer Center at Saint Francis Hospital and Medical Center
Hartford, Connecticut
Mayo Clinic - Jacksonville
Jacksonville, Florida
MBCCOP - Medical College of Georgia Cancer Center
Augusta, Georgia
Saint Alphonsus Cancer Care Center at Saint Alphonsus Regional Medical Center
Boise, Idaho
CCOP - Carle Cancer Center
Urbana, Illinois
Elkhart Clinic, LLC
Elkhart, Indiana
Michiana Hematology-Oncology, PC - Elkhart
Elkhart, Indiana
Elkhart General Hospital
Elkhart, Indiana
Howard Community Hospital
Kokomo, Indiana
Center for Cancer Therapy at LaPorte Hospital and Health Services
La Porte, Indiana
Indiana University Health La Porte Hospital
La Porte, Indiana
Michiana Hematology-Oncology, PC - South Bend
Mishawaka, Indiana
Saint Joseph Regional Medical Center
Mishawaka, Indiana
Michiana Hematology Oncology PC-Mishawaka
Mishawaka, Indiana
Michiana Hematology Oncology PC - Plymouth
Plymouth, Indiana
CCOP - Northern Indiana CR Consortium
South Bend, Indiana
Memorial Hospital of South Bend
South Bend, Indiana
Michiana Hematology Oncology PC - La Porte
Westville, Indiana
McFarland Clinic, PC
Ames, Iowa
Cedar Rapids Oncology Associates
Cedar Rapids, Iowa
Mercy Regional Cancer Center at Mercy Medical Center
Cedar Rapids, Iowa
Boston University Cancer Research Center
Boston, Massachusetts
Hickman Cancer Center at Bixby Medical Center
Adrian, Michigan
Saint Joseph Mercy Cancer Center
Ann Arbor, Michigan
CCOP - Michigan Cancer Research Consortium
Ann Arbor, Michigan
Battle Creek Health System Cancer Care Center
Battle Creek, Michigan
Mecosta County Medical Center
Big Rapids, Michigan
Oakwood Cancer Center at Oakwood Hospital and Medical Center
Dearborn, Michigan
Saint John Hospital and Medical Center
Detroit, Michigan
Genesys Hurley Cancer Institute
Flint, Michigan
Hurley Medical Center
Flint, Michigan
Genesys Regional Medical Center
Grand Blanc, Michigan
Butterworth Hospital at Spectrum Health
Grand Rapids, Michigan
CCOP - Grand Rapids
Grand Rapids, Michigan
Lacks Cancer Center at Saint Mary's Health Care
Grand Rapids, Michigan
Van Elslander Cancer Center at St. John Hospital and Medical Center
Grosse Pointe Woods, Michigan
Allegiance Health
Jackson, Michigan
Foote Memorial Hospital
Jackson, Michigan
Sparrow Regional Cancer Center
Lansing, Michigan
Showing 40 of 120 sites, US sites first. The full list is on the registry record.
Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.
For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.